최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기지역사회간호학회지 = Journal of korean academy of community health nursing, v.29 no.3, 2018년, pp.279 - 289
심미소 (연세대학교 간호학과) , 김광숙 (연세대학교 간호대학.김모임 간호학연구소) , 박창기 (시카고 일리노이대학교 간호대학)
Purpose: This study has been conducted to identify factors that influence the initiation of treatment after the diagnosis of Korean patients with HIV. Methods: A cross-sectional study design was used, and 290 patients with HIV from outpatient departments of 7 hospitals participated. Self-report ques...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
과거에 비해 현재 HIV에 대한 치료 여부는 어떠한가? | 인간 면역결핍 바이러스(Human Immunodeficiency Virus, HIV) 감염은 과거에는 급성 감염성이면서 치료가 어려운 질환으로 인식되었으나, 1990년대 중반 항레트로바이러스 치료의 도입으로 HIV 감염인도 꾸준한 치료와 약물 복용을 통해 건강한 삶을 유지할 수 있게 되었다[1]. HIV 감염과 후천성 면역결핍 증후군(Acquired Immunodeficiency Syndrome, AIDS)의 대책에 관한 국제적인 활동을 하는 유엔의 기관인 유엔 에이즈 합동 계획(The Joint United Nations Programme on HIV/AIDS, UNAIDS)은 AIDS의 종식을 위해 2014년 90-90-90 목표를 제시하고 2020년까지 달성을 위해 노력하고 있다[2]. | |
국내 인간 면역결핍 바이러스 감염 추세와 연령 별 감염 인구는 어떠한가? | 국내 2016년 생존 내국인 HIV 감염인 수는 11,439명이며, 신규 내국인 HIV 감염인 수는 2013년 1,013명, 2014년 1,081명,2015년 1,018명, 2016년 1,062명으로 지속적으로 신규 감염이 발생하였다[3]. 2016년 기준 생존 감염인의 64.9%가 20~40대의 젊은 연령이며, 2016년 신규 내국인 HIV 감염인 1,062명 중에서도 20대가 33.9%(360명), 30대가 22.7%(241명), 40대가 18.2%(193명)로 20~40대가 전체의 74.8%를 차지하였다[3]. 지속적인 신규 감염인의 증가와 젊은 감염인의 높은 비율을 고려할 때, 진단을 받은 HIV 감염인의 조기치료의 향상은 HIV 감염인들의 기대여명 증가, 건강증진의 도모는 물론 국가적으로는 HIV 감염병의 철저한 관리를 위해 매우 중요하다. | |
HIV의 조기치료가 중요한 이유는? | 04배 낮았다[5]. 즉, 조기치료는 HIV 감염인의 질병으로 인한 합병증 예방을 통한 건강한 삶의 유지에 기여하고, 치료를 통해 HIV 감염인의 혈청 HIV 농도를 검출 불가능한 수준으로 통제할 경우 HIV 전파의 감소에도 기여할수 있어 공중보건학적으로도 HIV 감염인의 진단 후 조기치료는 매우 중요하다[7]. 국내의 경우, 2013년 12월 개정된 대한에이즈학회의 HIV 감염의 진단과 치료에 대한 임상진료지침 권고안에서 모든 HIV 감염인에게 조기치료를 시행할 것을 권고하였으므로[8], 이러한 진료 지침의 개정이 HIV 감염인의 조기치료에 영향을 주었는지 확인할 필요가 있다. |
Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. The Lancet. 2013;382(9903):1525-1533. https://doi.org/10.1016/S0140-6736(13)61809-7
The Joint United Nations Programme on HIV/AIDS. Ending AIDS: progress towards the 90-90-90 targets [Internet]. Geneva: The Joint United Nations Programme on HIV/AIDS. 2017 [cited 2018 January 3]. Available from: http://www.unaids.org/sites/default/files/media_asset/Global_AIDS_update_2017_en.pdf
Korea Centers for Disease Control & Prevention. 2016 annual report on the notified patients with HIV/AIDS [Internet]. Cheongju: Korea Centers for Disease Control & Prevention. 2017 [cited 2017 March 24]. Available from: http://cdc.go.kr/CDC/mobile/info/CdcKrInfo0128.jsp?menuIdsHOME001-MNU1130-MNU1156-MNU1426-MNU1448&fid3444&q_type&q_value&cid75787&pageNum
Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial. The Lancet Infectious Diseases. 2014;14(4):281-290. https://doi.org/10.1016/S1473-3099(13)70692-3
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine. 2011;365(6):493-505. https://doi.org/10.1056/NEJMoa1105243
Insight Start Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. The New England Journal of Medicine. 2015;2015(373):795-807. https://doi.org/10.1056/NEJMoa1506816
Centers for Disease Control & Prevention. Division of HIV/ AIDS Prevention Strategic Plan 2017-2020 [Internet]. Georgia: Centers for Disease Control & Prevention. 2018. [cited 2018 May 30]. Available from: https://www.cdc.gov/hiv/pdf/dhap/cdc-hiv-dhap-external-strategic-plan.pdf
The Korean Society for AIDS. The 2013 clinical guidelines for the diagnosis and treatment of HIV/AIDS in HIV-infected Koreans. Infection & Chemotherapy. 2013;45(4):455-461. https://doi.org/10.3947/ic.2013.45.4.455
Liu Y, Ruan Y, Vermund SH, Osborn CY, Wu P, Jia Y, et al. Predictors of antiretroviral therapy initiation: A cross-sectional study among Chinese HIV-infected men who have sex with men. BMC Infectious Diseases. 2015;15(1):570. https://doi.org/10.1186/s12879-015-1309-x
Palmer AK, Cescon A, Chan K, Cooper C, Raboud JM, Miller CL, et al. Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada. Journal of the International Association of Providers of AIDS Care. 2014;13 (1):56-62. https://doi.org/10.1177/2325957413510606
Hsu LC, Truong HHM, Vittinghoff E, Zhi Q, Scheer S, Schwarcz S. Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007-2011. The Journal of Infectious Diseases. 2013; 209(9):1310-1314. https://doi.org/10.1093/infdis/jit599
Alvarez-Uria G. Factors associated with delayed entry into HIV medical care after HIV diagnosis in a resource-limited setting: data from a cohort study in India. PeerJ. 2013;1:e90. https://doi.org/10.7717/peerj.90
Plitt SS, Mihalicz D, Singh AE, Jayaraman G, Houston S, Lee BE. Time to testing and accessing care among a population of newly diagnosed patients with HIV with a high proportion of Canadian Aboriginals, 1998-2003. AIDS Patient Care and STDs. 2009;23(2):93-99. https://doi.org/10.1089/apc.2007.0238
Newman CE, Bonar M, Greville HS, Thompson SC, Bessarab D, Kippax SC. Barriers and incentives to HIV treatment uptake among Aboriginal people in Western Australia. AIDS. 2007; 21:S13-S17. https://doi.org/10.1097/01.aids.0000255080.46976.18
Begley K, McLaws ML, Ross MW, Gold J. Cognitive and behavioural correlates of non-adherence to HIV anti-retroviral therapy: Theoretical and practical insight for clinical psychology and health psychology. Clinical Psychologist. 2008;12(1):9-17. https://doi.org/10.1080/09540121.2015.1114992
Coxe S, West SG, Aiken LS. The analysis of count data: a gentle introduction to Poisson regression and its alternatives. Journal of Personality Assessment. 2009;91(2):121-136. https://doi.org/10.1080/00223890802634175
Alvarez-Uria G, Pakam R, Midde M, Naik PK. Predictors of delayed antiretroviral therapy initiation, mortality, and loss to followup in HIV infected patients eligible for HIV treatment: Data from an HIV cohort study in India. BioMed Research International. 2013;2013:849042. https://doi.org/10.1155/2013/849042
Cescon A, Patterson S, Davey C, Ding E, Raboud JM, Chan K, et al. Late initiation of combination antiretroviral therapy in Canada: A call for a national public health strategy to improve engagement in HIV care. Journal of the International AIDS Society. 2015;18(1):20024. https://doi.org/10.7448/IAS.18.1.20024
Kohli R, Klein RS, Schoenbaum EE, Anastos K, Minkoff H, Sacks HS. Aging and HIV infection. Journal of Urban Health. 2006;83(1):31-42. https://doi.org/10.1007/s11524-005-9005-6
Illa L, Echenique M, Jean GS, Bustamante-Avellaneda V, Metsch L, Mendez-Mulet L, et al. Project ROADMAP: Reeducating Older Adults in Maintaining AIDS Prevention: A secondary intervention for older HIV-positive adults. AIDS Education & Prevention. 2010;22(2):138-147. https://doi.org/10.1521/aeap.2010.22.2.138
Messer LC, Quinlivan EB, Parnell H, Roytburd K, Adimora AA, Bowditch N, et al. Barriers and facilitators to testing, treatment entry, and engagement in care by HIV-positive women of color. AIDS Patient Care and STDs. 2013;27(7):398-407. https://doi.org/10.1089/apc.2012.0435
Logie CH, James L, Tharao W, Loutfy MR. HIV, gender, race, sexual orientation, and sex work: A qualitative study of intersectional stigma experienced by HIV-positive women in Ontario, Canada. PLoS Medicine. 2011;8(11):e1001124. https://doi.org/10.1371/journal.pmed.1001124
Alfonso V, Bermbach N, Geller J, Montaner JS. Individual variability in barriers affecting people's decision to take HAART: A qualitative study identifying barriers to being on HAART. AIDS Patient Care & STDs. 2006;20(12):848-857. https://doi.org/10.1089/apc.2006.20.848
Nakimuli-Mpungu E, Wamala K, Okello J, Alderman S, Odokonyero R, Mojtabai R, et al. Group support psychotherapy for depression treatment in people with HIV/AIDS in northern Uganda: A single-centre randomised controlled trial. The Lancet HIV. 2015;2(5):e190-e199. https://doi.org/10.1016/S2352-3018(15)00041-7
Fox MP, Mazimba A, Seidenberg P, Crooks D, Sikateyo B, Rosen S. Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: A cross-sectional study of cost, stigma, and perceptions about ART. Journal of the International AIDS Society. 2010;13(1):8. https://doi.org/10.1186/1758-2652-13-8
Posse M, Baltussen R. Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care and STDs. 2009;23(10):867-875. https://doi.org/10.1089/apc.2009.0050.
Korea Centers for Disease Control & Prevention. 2018 HIV/ AIDS management guideline [Internet]. Cheongju: Korea Centers for Disease Control & Prevention. 2017 [cited 2018 May 30]. Available from: http://www.cdc.go.kr/CDC/cms/content/mobile/74/77274_view.html
※ AI-Helper는 부적절한 답변을 할 수 있습니다.